A total of 104 strains of Haemophilus influenzae isolated from pediatric patients over a 1-year period were tested for susceptibility to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin. Of these strains, 30 produced ,8-lactamase. LY127935 inhibited 99% of the strains at a concentration of 0.125,tg/ml; the remaining strain was inhibited by this antibiotic at 0.25,ug/ml. ,B-Lactamase-producing strains were inhibited by ampicillin at 22 Ag/ml. f,-Lactamase-negative strains were all inhibited by ampicillin at c1 ,tg/ml, except for one nontypable strain which required 2,tg of ampicillin per ml for inhibition.
The emergence in 1974 (3, 4) of ampicillinresistant Haemophilus influenzae type b dictated the use of chloramphenicol for the treatment of serious infections due to this organism (10) . The prevalence of ampicillin-resistant strains varies in different regions of the country (3, 4) ; in our pediatric population, the incidence of ampicillin-resistant H. influenzae type b has risen from 1.6% in 1974 to 14 The susceptibility of 104 strains of H. influenzae to compound LY127935, ampicillin, chloramphenicol, and ticarcillin is shown in Table 1 . All strains, regardless of capacity to produce ,Blactamase, were inhibited by compound LY127935 at 0.25 ,ug/ml. In contrast, susceptibility to ampicillin was correlated directly with B8-lactamase production in all but one strain. All of the strains which did not elaborate ,B-lactamase were inhibited by ampicillin at sl ,ug/ml, except for one nontypable isolate from a tracheal aspirate. All strains which elaborated fB-lactamase required 22 ,ug of ampicillin per ml for inhibition. Chloramphenicol inhibited all strains of H. influenzae at c4 ,ug/ml. Of 104 isolates, 97 (93.3%) were inhibited by c8 ,ug of ticarcillin per ml. The geometric mean MIC of ticarcillin for f8-lactamase-positive strains was 4.702 ,ug/ml, and that for 8?-lactamase-negative strains was 0.331 ug/ml. (3, 4) , chloramphenicol has been recommended as one of the antibiotics to be used in the initial management of severe infections due to H. influenzae (10) . Although choramphenicol remains an effective drug for treatment of H. influenzae, it is associated with hematopoietic depression, and recently, chloramphenicol-resistant H. influ- 
